EP3444363
BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.5.2012EP published:
25.11.2020EP application number:
18197141.7
EPO information:
European Patent Register
Max expiry date:
30.5.2032
Title:
BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
Timeline
Today
31.5.2012EP application
25.11.2020EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088, JP
Inventor
Name:
Funahashi, YasuhiroAddress:
Ibaraki, 300-2635, JP
Name:
Kadowaki, TadashiAddress:
Ibaraki, 300-2635, JP
Name:
Matsui, JunjiAddress:
Ibaraki, 300-2635, JP
Name:
Simon, Jason S.Address:
Woodcliff Lake, NJ 07677, US
Name:
XU, LucyAddress:
Woodcliff Lake, NJ 07677, US
Priority
Number:
201161493294 PDate:
3.6.2011Country:
US
Classification
Categories:
C12Q 1/6886, G01N 33/574